ARS Investment Partners, LLC

Position in BHVN — Biohaven Ltd.

CIK 733020 New York, NY

Position in BHVN

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$20,447,872

+$8,782,988 QoQ

Shares Held

1,374,185

-0.3% QoQ

Ownership

0.910%

of shares outstanding

% of Portfolio

1.10%

of 13F equity value

Holder Rank

#25

of 294 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 8% Shared 0% None 92%

Healthcare · as of Jun 30, 2026

ARS Investment Partners, LLC holds $105,565,453 across 4 Biotechnology names. BHVN ranks #3 (19.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	210,462	$56,134,424
2	REGN	Regeneron Pharmaceuticals, Inc.	45,484	$28,361,093
3	BHVN	Biohaven Ltd. This page	1,374,185	$20,447,872
4	HRMY	Harmony Biosciences Holdings, Inc.	17,085	$622,064

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$20,447,872	1,374,185	-0.3%	Shares	Sole	2026-07-09
2026-03-31	$11,664,884	1,378,828	+11.2%	Shares	Sole	2026-04-16
2025-12-31	$13,995,084	1,239,600	+12.4%	Shares	Sole	2026-02-05
2025-09-30	$16,549,260	1,102,549	-7.2%	Shares	Sole	2025-10-15
2025-06-30	$16,764,457	1,188,126	+14.3%	Shares	Sole	2025-08-11
2025-03-31	$24,998,498	1,039,871	-0.1%	Shares	Sole	2025-05-14
2024-12-31	$38,870,593	1,040,712	+1.0%	Shares	Sole	2025-01-16
2024-09-30	$51,481,042	1,030,239	+9.5%	Shares	Sole	2024-10-16
2024-06-30	$32,645,171	940,512	+47.8%	Shares	Sole	2024-07-17
2024-03-31	$34,803,129	636,371	+0.4%	Shares	Sole	2024-05-02
2023-12-31	$27,133,659	633,964	+1.5%	Shares	Sole	2024-02-14
2023-09-30	$16,239,317	624,349	+0.1%	Shares	Sole	2023-11-13
2023-06-30	$14,912,660	623,439	+7.2%	Shares	Sole	2023-07-11
2023-03-31	$7,940,749	581,314	+3.0%	Shares	Sole	2023-04-05
2022-12-31	$7,831,637	564,239	—	Shares	Sole	2023-01-25
No filing history on record for this holder in this stock.